ArticleFrontiers in oncology2022

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma.

Shasha Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.